Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.46 |
| ▸ | KLK7 | P49862 | 6/20 | 0.41 |
| ▸ | RIPK1 | Q13546 | 4/20 | 0.41 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.40 |
| ▸ | KLK5 | Q9Y337 | 5/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.37 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.37 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.37 |
| ▸ | RORC | P51449 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | STS | P08842 | 1/20 | 0.34 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5887150 | 1.00 | ELANE (0.46) | ELANEKLK7RIPK1ABCB1KLK5 | |
| SCHEMBL5745497 | 1.00 | ELANE (0.46) | ELANEKLK7RIPK1ABCB1KLK5 | |
| SCHEMBL6333635 | 1.00 | ELANE (0.46) | ELANEKLK7RIPK1ABCB1KLK5 | |
| SCHEMBL15398080 | 0.93 | ELANE (0.43) | ELANEKLK7RIPK1ABCB1KLK5 | |
| SCHEMBL6853154 | 0.89 | ELANE (0.37) | ELANEKLK7RIPK1KLK5KDM4E | |
| SCHEMBL6853156 | 0.89 | ELANE (0.37) | ELANEKLK7RIPK1KLK5KDM4E | |
| SCHEMBL6853151 | 0.89 | ELANE (0.37) | ELANEKLK7RIPK1KLK5KDM4E | |
| SCHEMBL6859829 | 0.88 | TSHR (0.42) | RIPK1KDM4EGAAGPR119 | |
| SCHEMBL6859826 | 0.88 | TSHR (0.42) | RIPK1KDM4EGAAGPR119 | |
| SCHEMBL6859824 | 0.88 | TSHR (0.42) | RIPK1KDM4EGAAGPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8791279-B2 | Process for preparing taxoids from baccatin derivatives using lewis acid catalyst | YUNG SHIN PHARM. IND. CO., LTD. (TW) | 2014-07-29 | — | — | US | claimed |
| US-20120149925-A1 | PROCESS FOR PREPARING TAXOIDS FROM BACCATIN DERIVATIVES USING LEWIS ACID CATALYST | YUNG SHIN PHARM. IND. CO., LTD. (TW) | 2012-06-14 | — | — | US | claimed |
| US-11813241-B2 | Multi-arm polymeric prodrug conjugates of taxane-based compounds | NEKTAR THERAPEUTICS (US) | 2023-11-14 | — | — | US | disclosed |
| EP-2884963-B1 | STABLE PHARMACEUTICAL FORMULATION OF CABAZITAXEL | YUNG SHIN PHARM IND CO LTD (TW) | 2017-12-27 | — | — | EP | disclosed |
| US-20160340327-A1 | PROCESS FOR PREPARING AMORPHOUS CABAZITAXEL | SHILPA MEDICARE LIMITED (IN) | 2016-11-24 | — | — | US | disclosed |
| US-20160340327-A1 | PROCESS FOR PREPARING AMORPHOUS CABAZITAXEL | SHILPA MEDICARE LIMITED (IN) | 2016-11-24 | — | — | US | disclosed |
| US-20160235705-A1 | MULTI-ARM POLYMERIC PRODRUG CONJUGATES OF TAXANE-BASED COMPOUNDS | NEKTAR THERAPEUTICS | 2016-08-18 | — | — | US | disclosed |
| US-20160235705-A1 | MULTI-ARM POLYMERIC PRODRUG CONJUGATES OF TAXANE-BASED COMPOUNDS | NEKTAR THERAPEUTICS | 2016-08-18 | — | — | US | disclosed |
| US-9198969-B2 | Stable pharmaceutical formulation of cabazitaxel | YUNG SHIN PHARM. IND. CO., LTD. (TW) | 2015-12-01 | — | — | US | disclosed |
| US-20150315164-A1 | PROCESS FOR PREPARING AMORPHOUS CABAZITAXEL | SHILPA MEDICARE LIMITED (IN) | 2015-11-05 | — | — | US | disclosed |
| US-20150315164-A1 | PROCESS FOR PREPARING AMORPHOUS CABAZITAXEL | SHILPA MEDICARE LIMITED (IN) | 2015-11-05 | — | — | US | disclosed |
| EP-0577083-A1 | 7,8-cyclopropataxanes with antitumor action | Bristol-Myers Squibb Company (US) | 1994-01-05 | — | — | EP | disclosed |
| US-5274124-A | Metal alkoxides | FLORIDA STATE UNIVERSITY (US) | 1993-12-28 | — | — | US | disclosed |
| US-5272171-A | Phosphonooxy and carbonate derivatives of taxol | BRISTOL-MYERS SQUIBB COMPANY (US) | 1993-12-21 | — | — | US | disclosed |
| US-5254580-A | 7,8-cyclopropataxanes | BRISTOL-MYERS SQUIBB COMPANY (US) | 1993-10-19 | — | — | US | disclosed |
| EP-0558959-A1 | Phosphonooxy and carbonate derivatives of taxol | Bristol-Myers Squibb Company (US) | 1993-09-08 | — | — | EP | disclosed |
| US-5229526-A | METAL ALKOXIDES | FLORIDA STATE UNIVERSITY (US) | 1993-07-20 | — | — | US | disclosed |
| WO-1993006079-A1 | PREPARATION OF SUBSTITUTED ISOSERINE ESTERS USING METAL ALKOXIDES AND β-LACTAMS | FLORIDA STATE UNIVERSITY (US) | 1993-04-01 | — | — | WO | disclosed |
| WO-1993006094-A1 | METAL ALKOXIDES | FLORIDA STATE UNIVERSITY (US) | 1993-04-01 | — | — | WO | disclosed |
| WO-1993006093-A1 | 10-DESACETOXYTAXOL DERIVATIVES | FLORIDA STATE UNIVERSITY (US) | 1993-04-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160340327-A1 | PROCESS FOR PREPARING AMORPHOUS CABAZITAXEL | RCC1, CSPP1, INCENP | ELANE 4278/4885KLK7 447/4885RIPK1 3218/4885 |
| US-11813241-B2 | Multi-arm polymeric prodrug conjugates of taxane-based compounds | PAICS, FOLR1, FOLR2 | ELANE 542/4885KLK7 988/4885RIPK1 4398/4885 |
| US-20160235705-A1 | MULTI-ARM POLYMERIC PRODRUG CONJUGATES OF TAXANE-BASED COMPOUNDS | PAICS, FOLR1, FOLR2 | ELANE 542/4885KLK7 988/4885RIPK1 4398/4885 |
| US-20120149925-A1 | PROCESS FOR PREPARING TAXOIDS FROM BACCATIN DERIVATIVES USING LEWIS ACID CATALYST | TBCA, CEL, LTN1 | ELANE 82/4885KLK7 787/4885RIPK1 3764/4885 |
| US-20150315164-A1 | PROCESS FOR PREPARING AMORPHOUS CABAZITAXEL | RCC1, CSPP1, INCENP | ELANE 4278/4885KLK7 447/4885RIPK1 3218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.